|Table of Contents|

Age period cohort analysis of leukemia incidence and mortality in China from 1990 to 2019

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2024 07
Page:
1334-1340
Research Field:
Publishing date:

Info

Title:
Age period cohort analysis of leukemia incidence and mortality in China from 1990 to 2019
Author(s):
WANG Lanlan1; LIU Guangchao2; LI Xiaofan1; HAO Jianping1
1.Hematology Center,the First Affiliated Hospital of Xinjiang Medical University,Xinjiang Urumqi 830054,China;2.Public Health Institute of Xinjiang Medical University,Xinjiang Urumqi 830011,China.
Keywords:
leukemia; Joinpoint regression model; age-period-cohort model
PACS:
R733.3
DOI:
10.3969/j.issn.1672-4992.2024.07.027
Abstract:
Objective:To analyse the trends of leukaemia incidence and death in Chinese residents with age,period and cohort from 1990 to 2019,and to provide a reference basis for leukemia research.Methods:Based on the leukemia incidence and mortality data of Chinese residents from 1990 to 2019,the trends of leukemia incidence and mortality were analyzed using Joinpoint regression models.The age-period-cohort model (APC model) was used to analyze the effects of age,period,and cohort on changes in incidence and mortality.Results:The average annual percentage change (AAPC) in morbidity rates for males and females in the Chinese population from 1990 to 2019 was -0.35 (P＜0.01) and -0.98 (P＜0.01),respectively,and in mortality rates for males and females,the AAPC was -1.5 3(P＜0.01) and -2.28 (P＜0.01),respectively.The esults of the APC model showed that:Age-specific risks of incidence and mortality decreased and then increased with age,with a U-shaped distribution.Period-specific risks of incidence increased with period-specific risk,and period-specific risks of mortality decreased,and cohort-specific risks of incidence and mortality increased and then decreased with birth cohort.Conclusion:The national leukaemia incidence and mortality rates from 1990 to 2019 are generally on a downward trend,and the risk of leukaemia incidence and mortality in the population is greatly affected by age,period and birth cohort,so strengthening the prevention and treatment of high-risk groups will help to reduce the disease burden of leukaemia in China.

References:

［1］SHI Y,CHEN C,HUANG Y,et al.Global disease burden and trends of leukemia attributable to occupational risk from 1990 to 2019:An observational trend study ［J］.Front Public Health,2022,10:1015861.
［2］SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries ［J］.CA Cancer J Clin,2021,71(3):209-249.
［3］RONGSHOU Z,SIWEI Z,HONGMEI Z,et al.Cancer incidence and mortality in China,2016 ［J］.Journal of the National Cancer Center,2022,2(1):1-9.
［4］秦天燕,高彩云,丁高恒，等.2018年甘肃省肿瘤登记地区白血病流行特征及2010-2018年变化趋势［J］.中国肿瘤,2022,31(11):885-891. QIN TY，GAO CY，DING GH,et al.Epidemic characteristics of leukemia in tumor registration areas of Gansu province in 2018 and trends from 2010 to 2018 ［J］.China Cancer,2022,31(11):885-891.
［5］丁璐璐,张永辉,徐源佑,等.江苏省启东市1972-2016年白血病生存率长期趋势分析 ［J］.中国肿瘤,2022,31(11):892-897. DING LL，ZHANG YH，XU YY，et al.Long term trend analysis of leukemia survival rate in Qidong city,Jiangsu province from 1972 to 2016［J］.China Cancer,2022,31(11):892-897.
［6］LI B,TANG H,CHENG Z,et al.The current situation and future trend of leukemia mortality by sex and area in China ［J］.Front Public Health,2020,8:598215.
［7］YIN M,WANG F,ZHANG Y,et al.Analysis on incidence and mortality trends and age-period-cohort of breast cancer in Chinese women from 1990 to 2019 ［J］.Int J Environ Res Public Health,2023,20(1):826-836.
［8］GBD 2019 Diseases and Injuries Collaborators.Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:A systematic analysis for the global burden of disease study 2019 ［J］.Lancet,2020,396(10258):1204-1222.
［9］GBD 2019 Hepatitis B Collaborators.Global,regional,and national burden of hepatitis B,1990-2019:A systematic analysis for the global burden of disease study 2019 ［J］.Lancet Gastroenterol Hepatol,2022,7(9):796-829.
［10］屈彦,王天一,杨津,等.GBD数据库的数据提取方法与流程 ［J］.中国循证心血管医学杂志,2019,11(09):1043-1046. QU Y,WANG TY,YANG J,et al.The method and process of data extraction in GBD database［J］.Chinese Journal of Evidence Based Cardiovascular Medicine,2019,11(09):1043-1046.
［11］LI Y,NING Y,SHEN B,et al.Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019:An analysis of the global burden of disease study 2019 ［J］.Clin Kidney J,2023,16(2):312-321.
［12］蒋远东,腾子豪,王玥,等.1990―2019年中国结核病发病趋势的年龄-时期-队列模型分析［J］.中华疾病控制杂志,2022,26(11):1275-1282. JIANG YD,TENG ZH,WANG Y,et al.Age period cohort model analysis of tuberculosis incidence trend in China from 1990 to 2019［J］.Chinese Journal of Disease Control,2022,26(11):1275-1282.
［13］戴萌娜,袭燕,尹文强,等.中国居民1990-2019年白血病疾病负担趋势分析［J］.中国公共卫生,2022,38(05):539-546. DAI MN,XI Y,YIN WQ,et al.Analysis of the trend of leukemia disease burden among Chinese residents from 1990 to 2019 ［J］.China Public Health,2022,38(05):539-546.
［14］喻静,姜海虹,刘欢,等.1990-2019年中国白血病疾病负担变化趋势及危险因素分析［J］.公共卫生与预防医学,2022,33(05):23-28. YU J,JIANG HH,LIU H,et al.Analysis of the trends and risk factors of leukemia disease burden in China from 1990 to 2019 ［J］.Public Health and Preventive Medicine,2022,33(05):23-28.
［15］KHORRAMI Z,POURKHOSRAVANI M,ESLAHI M,et al.Multiple air pollutants exposure and leukaemia incidence in Tehran,Iran from 2010 to 2016:a retrospective cohort study ［J］.BMJ Open,2022,12(6):e060562.
［16］ZJABLOVSKAJA P,FLORIAN MC.Acute myeloid leukemia:Aging and epigenetics［J］.Cancers (Basel),2019,12(1):103-120.
［17］PROTANO C,BUOMPRISCO G,CAMMALLERI V,et al.The carcinogenic effects of formaldehyde occupational exposure:A systematic review ［J］.Cancers (Basel),2021,14(1):165-176.
［18］FASIH RAMANDI N,FARANOUSH M,GHASSEMPOUR A,et al.Mass spectrometry:A powerful method for monitoring various type of leukemia,especially MALDI-TOF in leukemia's proteomics studies review ［J］.Crit Rev Anal Chem,2022,52(6):1259-1286.
［19］HERRMANN H,SADOVNIK I,EISENWORT G,et al.Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AmL and CmL ［J］.Blood Adv,2020,4(20):5118-5132.
［20］BRIVIO E,BARUCHEL A,BEISHUIZEN A,et al.Targeted inhibitors and antibody immunotherapies:Novel therapies for paediatric leukaemia and lymphoma ［J］.Eur J Cancer,2022,164:1-17.
［21］CI T,ZHANG W,QIAO Y,et al.Delivery strategies in treatments of leukemia ［J］.Chem Soc Rev,2022,51(6):2121-2144.
［22］SHAO Y,HUA Z,ZHAO L,et al.Time trends of gastrointestinal cancers incidence and mortality in yangzhong from 1991 to 2015:An updated age-period-cohort analysis ［J］.Front Oncol,2018,8:638.
［23］COHEN AK,SYME SL.Education:a missed opportunity for public health intervention ［J］.Am J Public Health,2013,103(6):997-1001.

Memo

Memo:
National Natural Science Foundation of China（No.82260032）;国家自然科学基金资助项目(编号:82260032)
Last Update: 2024-02-29